JP2022544964A5 - - Google Patents

Info

Publication number
JP2022544964A5
JP2022544964A5 JP2022509630A JP2022509630A JP2022544964A5 JP 2022544964 A5 JP2022544964 A5 JP 2022544964A5 JP 2022509630 A JP2022509630 A JP 2022509630A JP 2022509630 A JP2022509630 A JP 2022509630A JP 2022544964 A5 JP2022544964 A5 JP 2022544964A5
Authority
JP
Japan
Application number
JP2022509630A
Other languages
Japanese (ja)
Other versions
JP7764364B2 (ja
JPWO2021032961A5 (https=
JP2022544964A (ja
Filing date
Publication date
Priority claimed from GBGB1911799.3A external-priority patent/GB201911799D0/en
Priority claimed from GBGB2010760.3A external-priority patent/GB202010760D0/en
Priority claimed from GBGB2012172.9A external-priority patent/GB202012172D0/en
Priority claimed from PCT/GB2020/051956 external-priority patent/WO2021032961A1/en
Application filed filed Critical
Publication of JP2022544964A publication Critical patent/JP2022544964A/ja
Publication of JP2022544964A5 publication Critical patent/JP2022544964A5/ja
Publication of JPWO2021032961A5 publication Critical patent/JPWO2021032961A5/ja
Priority to JP2025121129A priority Critical patent/JP2025165980A/ja
Publication of JP7764364B2 publication Critical patent/JP7764364B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022509630A 2019-08-16 2020-08-14 エクスビボγδ T細胞集団 Active JP7764364B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025121129A JP2025165980A (ja) 2019-08-16 2025-07-18 エクスビボγδ T細胞集団

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1911799.3A GB201911799D0 (en) 2019-08-16 2019-08-16 Novel Antibodies
GB1911799.3 2019-08-16
GB2010760.3 2020-07-13
GBGB2010760.3A GB202010760D0 (en) 2020-07-13 2020-07-13 Novel antibodies
GB2012172.9 2020-08-05
GBGB2012172.9A GB202012172D0 (en) 2020-08-05 2020-08-05 Gamma delta cell populations
PCT/GB2020/051956 WO2021032961A1 (en) 2019-08-16 2020-08-14 Ex vivo gamma delta t cell populations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025121129A Division JP2025165980A (ja) 2019-08-16 2025-07-18 エクスビボγδ T細胞集団

Publications (4)

Publication Number Publication Date
JP2022544964A JP2022544964A (ja) 2022-10-24
JPWO2021032961A5 JPWO2021032961A5 (https=) 2023-08-21
JP2022544964A5 true JP2022544964A5 (https=) 2023-08-21
JP7764364B2 JP7764364B2 (ja) 2025-11-05

Family

ID=72148175

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022509630A Active JP7764364B2 (ja) 2019-08-16 2020-08-14 エクスビボγδ T細胞集団
JP2025121129A Pending JP2025165980A (ja) 2019-08-16 2025-07-18 エクスビボγδ T細胞集団

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025121129A Pending JP2025165980A (ja) 2019-08-16 2025-07-18 エクスビボγδ T細胞集団

Country Status (12)

Country Link
US (1) US20220290101A1 (https=)
EP (1) EP4013787A1 (https=)
JP (2) JP7764364B2 (https=)
KR (1) KR20220045980A (https=)
CN (1) CN114599783A (https=)
AU (1) AU2020334287A1 (https=)
BR (1) BR112022001416A2 (https=)
CA (1) CA3148588A1 (https=)
IL (1) IL290538A (https=)
MX (1) MX2022001977A (https=)
PH (1) PH12022550373A1 (https=)
WO (1) WO2021032961A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107531787B (zh) 2015-01-27 2022-01-18 拉法医疗有限公司 靶向cd1d的单域抗体
WO2020060406A1 (en) 2018-09-19 2020-03-26 Lava Therapeutics B.V. Novel bispecific antibodies for use in the treatment of hematological malignancies
EP4114415A1 (en) 2020-03-06 2023-01-11 Sorrento Therapeutics, Inc. Innate immunity killer cells targeting psma positive tumor cells
CN116323667A (zh) 2020-07-08 2023-06-23 拉法医疗股份有限公司 结合PSMA和γ-δT细胞受体的抗体
LT4269444T (lt) 2020-08-14 2024-09-25 GammaDelta Therapeutics Limited Daugiaspecifiniai anti-tcr kintamos delta 1 antikūnai
GB202013962D0 (en) 2020-09-04 2020-10-21 Gammadelta Therapeutics Ltd Immunotherapy composition
TW202246338A (zh) * 2021-02-17 2022-12-01 英商適應生物治療有限公司 抗TCRδ可變1抗體
AU2022222299A1 (en) 2021-02-17 2023-09-07 F-Star Therapeutics Limited Multispecific anti-tcr delta variable 1 antibodies
JP2024539088A (ja) * 2021-10-20 2024-10-28 ユニバーシティ オブ ピッツバーグ -オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション 腫瘍浸潤ガンマ-デルタt細胞を拡大するための方法及び材料
CA3238458A1 (en) * 2021-11-18 2023-05-25 Regents Of The University Of Minnesota Large-scale expansion of engineered human gamma delta t cells
WO2024259371A2 (en) * 2023-06-14 2024-12-19 Duke University COMPOSITIONS FOR AND METHODS OF EXPANDING γδ T CELLS
CN121752599A (zh) * 2023-08-31 2026-03-27 南京传奇生物科技有限公司 抗γδTCR抗体及其用途
CN120058919B (zh) * 2025-04-29 2025-07-18 浙江大学杭州国际科创中心 抗裂谷热病毒Gn蛋白的单抗及在病毒检测中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103635573B (zh) 2011-05-19 2016-05-11 分子医学研究所 包含γδT细胞的淋巴细胞系、其组合物及生产方法
GB201506423D0 (en) * 2015-04-15 2015-05-27 Tc Biopharm Ltd Gamma delta T cells and uses thereof
AU2016274633B2 (en) 2015-06-09 2022-04-21 Gammadelta Therapeutics Ltd Methods for the production of TCR gamma delta+ T cells
EP4148124A1 (en) 2015-10-30 2023-03-15 Cancer Research Technology Limited Expansion of non-haematopoietic tissue-resident gamma delta t cells and uses of these cells
EP3454870A4 (en) 2016-05-12 2020-03-04 Adicet Bio Inc. METHOD FOR SELECTIVE EXPANSION OF GAMMA DELTA T CELL POPULATIONS AND COMPOSITIONS THEREOF
US10546518B2 (en) 2017-05-15 2020-01-28 Google Llc Near-eye display with extended effective eyebox via eye tracking
US10519236B2 (en) * 2018-01-23 2019-12-31 New York University Antibodies specific to delta 1 chain of T cell receptor
GB201818243D0 (en) 2018-11-08 2018-12-26 Gammadelta Therapeutics Ltd Methods for isolating and expanding cells

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022544964A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)